companydata.dkGXP PHARMAID ApS: Financial statements 2013
CVR: 29615861
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 2,306,234 and a net result of DKK 450,698. That is an increase of 11.6% compared with the year before. Equity amounted to DKK 1,133,768. The solvency ratio was 44%.
- Gross Profit
- 2,306,234 kr.
- Profit/Loss
- 450,698 kr.
- Equity
- 1,133,768 kr.
- Total Assets
- 2,579,427 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 2.3 mio. | 451 t. | 1.1 mio. | - |
| 2012 | - | 2.1 mio. | - | - | - |
Events in 2013
As of October 30, 2013, Nusret Asanovski has joined the board of directors of GXP PHARMAID ApS.
As of October 30, 2013, Jonas Evjenios Markou has joined the board of directors of GXP PHARMAID ApS.
As of October 30, 2013, Mogens Birch-Larsen has joined the board of directors of GXP PHARMAID ApS.
GXP PHARMAID ApS has published its annual report for 2012.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 2 employees. In 2024, the company reported a gross profit of DKK 1,340,825 and a net result of DKK 216,532 compared with DKK 513,163 the year before. Equity amounted to DKK 1,096,211.